Bristol Myers Squibb to acquire MyoKardia for $13.1 billion in cash
On Oct. 5, 2020, Bristol-Myers and MyoKardia announced a definitive merger agreement under which Bristol Myers Squibb will…
-
-
Data from Corvus phase 1 study of CPI-006 continued to support its potential as treatment for COVID-19
On Oct. 5, 2020, Corvus Pharmaceuticals announced updated data from its ongoing Phase 1 study investigating the potential…
-
NIH awarded $13.8 million for studies on the prevention and treatment of Alzheimer’s disease
On Oct. 5, 2020, Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert…
-
Fred Hutch opened COVID-19 clinical research center
On Oct. 5, 2020, the Fred Hutchinson Cancer Research Center announced the opening of the COVID-19 Clinical Research…
-
Biotechnology | Chemistry | FDA | Oncology | Therapeutics
FDA approved drug combination for treating mesothelioma
On Oct. 1, 2020, the U.S. Food and Drug Administration announced it had approved Opdivo (nivolumab) in combination…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine | WHO
WHO welcomed $90 million contribution from Kingdom of Saudi Arabia to support COVID-19 global response
On Oct. 2, 2020, the World Health Organization (WHO) and the Kingdom of Saudi Arabia signed a contribution…
-
Quidel received Emergency Authorization for rapid antigen ‘ABC test’ assay for Influenza A+B and COVID-19
On Oct. 2, 2020, Quidel announced that it had received Emergency Use Authorization from the U.S. Food and…
-
UConn funded five COVID-19 research projects, announced additional funding
On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) announced a new internal…
-
LabCorp COVID-19 molecular test innovation received FDA authorization
On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the U.S….
-
Johnson & Johnson completed acquisition of Momenta Pharmaceuticals for $65 billion
On Oct. 1, 2020, Johnson & Johnson announced it had successfully completed its acquisition of Momenta Pharmaceuticals, a…
-
19 organizations from the healthcare community unite to form COVID-19 testing industry consortium
On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…
-
Gilead Sciences updated supply and distribution of Veklury (remdesivir) in the US
On Oct. 1, 2020, Gilead Sciences announced that it will be responsible for distributing Veklury in the U.S….
-
Amyris delivered sustainable alternative to shark squalene adjuvant enabling vaccines with no sharks killed
On Oct. 1, 2020, Amyris announced that it has begun delivering samples to pharmaceutical companies of a sustainable…
-
Biotechnology | COVID-19 | Genomics | Infectious Disease | Non-Profit Research | Prehistory | Therapeutics | Vaccine
Neandertal gene variant increases risk of severe Covid-19
On Sept. 30, 2020, researchers at the Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary…
-
NIH assessed and expanded COVID-19 testing for underserved communities
On Sept. 30, 2020, the National Institutes of Health (NIH) announced that it had awarded nearly $234 million…
-
Oxford researchers started new trial on the use of anti-TNF to treat Covid-19 in care homes
On Sept. 30, 2020, University of Oxford researchers announced they had begun a new study to explore the…
-
UN welcome nearly $1 billion in pledges to bolster access to tests, treatments and vaccines to end COVID-19
On Sept. 30, 2020, the United Nations (UN) and its partners announced that nearly $1 billion in financing…
-
Sorrento Therapeutics and ViralClear entered agreement to explore combination antibody plus antiviral therapy against COVID-19
On Sept. 30, 2020, ViralClear Pharmaceuticals and Sorrento Therapeutics announced the companies were exploring the synergistic potential of…
-
Bio-Techne announced opening of GMP manufacturing facility in Twin Cities
On Sept. 30, 2020, Bio-Techne announced the opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing…
-
Quest Diagnostics launched three new combined COVID-19 and respiratory virus tests
On Sept. 30, 2020, Quest Diagnostics announced three different test options for healthcare providers across the U.S.to aid…
-
BD announced CE Mark of portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes
On Sept. 30, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
-
BioNTech and Pfizer announced Nature publication of German phase 1/2 study data from mRNA-based vaccine candidate against SARS-CoV-2
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
-
Hydroxychloroquine showed no benefit in COVID-19 prevention
On Sept. 30, 2020, researchers from the Perelman School of Medicine at the University of Pennsylvania reported results…
-
AXIM Biotechnologies filed patent for world’s first face mask designed to capture SARS-CoV-2 COVID-19
On Sept. 29, 2020, AXIM Biotechnologies announced that it has filed a provisional patent for a first-in-class face…
-
Windtree announced FDA acceptance of IND application for phase 2 clinical trial studying KL4 Surfactant in acute lung injury in adults with COVID-19
On Sept. 29, 2020, Windtree Therapeutics announced that U.S. Food and Drug Administration (FDA) has accepted its Investigational…
-
COVID-19 vaccine generated immune response in older adults
On Sept. 29, 2020, a phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection was…
-
Investigational COVID-19 vaccine well tolerated and generated iImmune response in older adults
On Sept. 29, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a phase 1…
-
Increased COVID-19 cases reported in US among adults aged 18-22 years
On Sept. 29, 2020, the Centers for Disease Control and Prevention (CDC) reported that during Aug. 2-Sept. 5,…
-
Computer-designed proteins may protect against coronavirus
On Sept. 29, 2020, the National Institutes of Health (NIH) announced that researchers had designed ”miniproteins’ that bound…
-
Oxford Immunotec announced FDA clearance of the T-SPOT.TB test for use in pediatrics over the age of two
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the U.S. Food and Drug…
